Helium Oxygen Mixture in the Treatment of Meconium Aspiration Syndrome

NCT02620891 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-01-07

No results posted yet for this study

Summary

Helium-oxygen mixture(heliox) was suggested to be beneficial in meconium aspiration syndrome in previous studies,but the evidence was limited.The aim of the study was to assess the effectiveness of synchronize intermittent mandatory ventilation (SIMV) with heliox (70% helium and 30% oxygen) on length of ventilation(LoV) and cardiopulmonary protection in meconium aspiration syndrome.

Conditions

  • Neonatal Meconium Aspiration

Interventions

DEVICE

helium oxygen mixture

Sponsors & Collaborators

  • Ma Juan

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
37 Weeks
Max Age
40 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-02-01
Primary Completion
2017-02-20
Completion
2017-04-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02620891 on ClinicalTrials.gov